Rolles, Benjamin
Mullally, Ann
Funding for this research was provided by:
NHLBI Division of Intramural Research (R01HL131835)
Gabrielle's Angel Foundation for Cancer Research
Leukemia and Lymphoma Society
Article History
Accepted: 10 October 2022
First Online: 7 November 2022
Declarations
:
: A.M. receives research funding from the Relay Therapeutics. A.M. has consulted for the Janssen, PharmaEssentia, Constellation, Aclaris Therapeutics, Cellarity, Morphic Therapeutics and Biomarin Pharmaceuticals. AM has received research funding from the Janssen and Actuate Therapeutics.
: This article does not contain any studies with human or animal subjects performed by any of the authors.